Finance

Lists
SAILIFE:NSE
Sai Life Sciences Ltd
1 513,90 INR
+0,17%
(+2,60) 1D
6 ოქტ, 09:58:51 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SAILIFE...
Open
1 520,00 INR
High
1 520,00 INR
Low
1 495,00 INR
Mkt. cap
316,03 მლრ.
Avg. vol.
726,33 ათ.
Volume
39,72 ათ.
P/E ratio
89,07
52-wk high
1 697,00 INR
52-wk low
783,85 INR
EPS
17,00 INR
No. of employees
5 ათ.
Open
1 520,00 INR
High
1 520,00 INR
Low
1 495,00 INR
Mkt. cap
316,03 მლრ.
Avg. vol.
726,33 ათ.
Volume
39,72 ათ.
P/E ratio
89,07
52-wk high
1 697,00 INR
52-wk low
783,85 INR
EPS
17,00 INR
No. of employees
5 ათ.
News stories
From web sources and news partners
Profile
Sai Life Sciences Limited is an Indian contract research, development, and manufacturing organisation, headquartered in Hyderabad, Telangana. The company provides drug discovery, development, contract manufacturing services for small-molecule new chemical entities to pharmaceutical and biotechnology companies. The company was established in Hyderabad in January 1999 as Sai Dru Syn Laboratories Limited. It was later renamed Sai Life Sciences Limited. It operates R&D and manufacturing facilities in India, the UK, and the USA. Wikipedia
About Sai Life Sciences Ltd
CEO-
Employees5,22 ათ.
Founded1999
Headquarters-
SectorHealth care
Websitesailife.com
Last report
7 აგვ. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
3,42 INR / 3,60 INR
-5,00%miss
Revenue / Est. (INR)
5,54 მლრდ. / 5,65 მლრდ.
-1,84%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,37 მლრდ.
5,56 მლრდ.
6,02 მლრდ.
5,54 მლრდ.
Cost of goods sold
1,40 მლრდ.
1,28 მლრდ.
2,27 მლრდ.
1,45 მლრდ.
Cost of revenue
1,40 მლრდ.
1,28 მლრდ.
2,27 მლრდ.
1,45 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,63 მლრდ.
1,73 მლრდ.
1,96 მლრდ.
1,80 მლრდ.
Operating expense
2,91 მლრდ.
2,85 მლრდ.
2,43 მლრდ.
3,07 მლრდ.
Total operating expenses
4,31 მლრდ.
4,13 მლრდ.
4,70 მლრდ.
4,52 მლრდ.
Operating income
1,06 მლრდ.
1,44 მლრდ.
1,32 მლრდ.
1,02 მლრდ.
Other non operating income
153,25 მლნ.
83,80 მლნ.
-333,80 მლნ.
35,43 მლნ.
EBT including unusual items
1,12 მლრდ.
1,34 მლრდ.
1,39 მლრდ.
979,74 მლნ.
EBT excluding unusual items
1,12 მლრდ.
1,42 მლრდ.
1,39 მლრდ.
979,74 მლნ.
Income tax expense
282,07 მლნ.
337,91 მლნ.
349,91 მლნ.
246,89 მლნ.
Effective tax rate
25,17%
25,19%
25,13%
25,20%
Other operating expenses
887,29 მლნ.
676,72 მლნ.
14,63 მლნ.
814,72 მლნ.
Net income
838,44 მლნ.
1,00 მლრდ.
1,04 მლრდ.
732,85 მლნ.
Net profit margin
15,60%
18,04%
17,31%
13,22%
Earnings per share
3,93
5,00
4,86
3,42
Interest and investment income
-
-
186,18 მლნ.
-
Interest expense
-93,51 მლნ.
-96,99 მლნ.
-78,25 მლნ.
-76,36 მლნ.
Net interest expenses
-93,51 მლნ.
-96,99 მლნ.
107,93 მლნ.
-76,36 მლნ.
Depreciation and amortization charges
397,48 მლნ.
440,75 მლნ.
453,08 მლნ.
459,37 მლნ.
EBITDA
1,45 მლრდ.
1,66 მლრდ.
1,60 მლრდ.
1,44 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები